Singapore-based biotech start-up MiRXES announced that it has received Provisional Authorization from the Health Sciences Authority (HSA) Singapore, to supply the Fortitude Kit SARS-CoV-2 real-time RT-PCR (reverse transcriptase polymerase chain reaction) test. With technology licensed from Singapore’s Agency for Science, Technology, and Research (A*STAR) and the HSA Provisional Authorization,...
